Biotechnology extensive list

Biotechnology extensive list
  • Pininvest Analysis

The Biotechnology theme offers an extensive selection of biotech firms listed on the NASDAQ stock exchange

For comparison purposes, the iShares Nasdaq Biotechnology ETF IBB seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ

The iShares fund offers a well-regarded sector view on U.S. biotechnology and pharmaceutical companies

 

The biotech selection of the theme is not weighted; performance and volatility are calculated for informative purpose only - assuming one share of each component had been invested at the beginning of the selected period

Actual performance of IBB, the tracker fund, which maybe higher or lower, depending on the weighting and  selection decided by the provider, please check the information available on the iShares Nasdaq Biotechnology  ETF site or contact your advisor

Biotechnology extensive list • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Momentum Vol. Risk Contrib. MDD
 
AC Immune ACIU NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 7.93 570 M 10.4% Weak Up 92%   1% -51%
ACADIA Pharmaceuticals Inc ACAD NASDAQ Health Care Drug Manufacturers - Diversified USD 26.03 4.2 B -50.0% Weak Up 79%   0% -66%
Acceleron Pharma XLRN NASDAQ Health Care Biopharmaceuticals USD 128.24 7.8 B 26.5% Neutral 40%   0% -19%
AcelRx Pharmaceuticals ACRX NASDAQ Health Care Drug Manufacturers - Diversified USD 1.39 165 M 2.2% Neutral 105%   1% -63%
Aclaris Therapeutics ACRS NASDAQ Health Care Biopharmaceuticals USD 18.29 947 M 1,029.0% Sharp Down 142%   0% -40%
Acorda Therapeutics Inc ACOR NASDAQ Health Care Biopharmaceuticals USD 4.46 42 M -11.3% Neutral 101%   0% -55%
Adamas Pharmaceuticals Inc ADMS NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 5.38 164 M 91.5% Neutral 81%   0% -44%
Adaptimmune Therapeutics ADAP NASDAQ Health Care Biopharmaceuticals USD 3.95 614 M -61.1% Sharp Down 77%   1% -63%
Adverum Biotechnologies ADVM NASDAQ Health Care Biopharmaceuticals USD 3.67 359 M -85.1% Sharp Down 119%   1% -87%
Aeglea BioTherapeutics AGLE NASDAQ Health Care Clinical trial work USD 6.44 309 M -38.7% Sharp Down 61%   0% -42%
Aerie Pharmaceuticals AERI NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 16.51 775 M 5.8% Neutral 51%   0% -43%
Agios Pharmaceuticals AGIO NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 60.46 4.2 B 25.6% Strong Up 53%   0% -41%
Akebia Therapeutics AKBA NASDAQ Health Care Clinical trial work USD 3.68 565 M -68.9% Weak Up 150%   1% -84%
Alexion Pharmaceuticals ALXN NASDAQ Health Care Biopharmaceuticals USD 180.69 40 B 51.4% Strong Up 36%   0% -16%
Alkermes Inc. ALKS NASDAQ Health Care Biopharmaceuticals USD 24.42 3.9 B 33.1% Strong Up 38%   0% -26%
Allakos ALLK NASDAQ Health Care Clinical trial work USD 91.86 4.9 B 15.2% Sharp Down 52%   0% -42%
AlloVir ALVR NASDAQ Health Care Immunotherapy USD 19.87 1.3 B -21.7% Weak Down 92%   1% -58%
Alnylam Pharmaceuticals ALNY NASDAQ Health Care Gene Editing - Cell Therapies USD 176.89 21 B 17.4% Weak Up 41%   0% -27%
ALX Oncology Holdings ALXO NASDAQ Health Care Oncology USD 59.29 2.4 B 97.6% Neutral 87%   0% -73%
Amarin AMRN NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 4.96 2.0 B -28.2% Neutral 67%   0% -52%
Amgen AMGN NASDAQ Health Care Biopharmaceuticals USD 238.68 138 B 1.3% Weak Down 25%   0% -16%
Amicus Therapeutics Inc. FOLD NASDAQ Health Care Drug Manufacturers - Diversified USD 9.93 2.6 B -34.9% Weak Up 61%   0% -65%
Amphastar Pharmaceuticals Inc AMPH NASDAQ Health Care Drug Manufacturers - Generic USD 20.17 957 M -4.0% Neutral 29%   0% -24%
Amyris AMRS NASDAQ Industrial Goods Chemicals - Major USD 15.83 4.2 B 303.8% Weak Up 107%   1% -52%
AnaptysBio ANAB NASDAQ Health Care Biopharmaceuticals USD 24.33 666 M 8.9% Neutral 71%   0% -46%
ANI Pharmaceuticals ANIP NASDAQ Health Care Drug Manufacturers - Generic USD 32.97 408 M 10.2% Neutral 49%   0% -28%
Annexon ANNX NASDAQ Health Care Clinical trial work USD 23.95 914 M 20.7% Weak Up 69%   0% -49%
Apellis Pharmaceuticals APLS NASDAQ Health Care Clinical trial work USD 60.11 4.8 B 88.2% Strong Up 60%   0% -29%
Applied Molecular Transport AMTI NASDAQ Health Care Immunotherapy USD 42.58 1.5 B 57.8% Neutral 92%   1% -46%
Aptinyx APTX NASDAQ Health Care Clinical trial work USD 3.10 207 M -29.5% Weak Up 70%   0% -52%
Aquestive Therapeutics AQST NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 4.07 147 M -25.5% Weak Up 85%   1% -64%
Arbutus Biopharma ABUS NASDAQ Health Care Biopharmaceuticals USD 3.25 311 M 70.2% Weak Up 119%   1% -62%
Arcutis Biotherapeutics ARQT NASDAQ Health Care Biopharmaceuticals USD 27.35 1.4 B -19.1% Neutral 70%   0% -51%
Ardelyx ARDX NASDAQ Health Care Biopharmaceuticals USD 7.28 718 M 7.1% Neutral 53%   0% -27%
Arena Pharmaceuticals ARNA NASDAQ Health Care Cannabinoid Therapeutics USD 67.04 4.0 B 6.3% Neutral 41%   0% -31%
argenx SE ARGX NASDAQ Health Care Biopharmaceuticals USD 318.16 14 B 47.2% Weak Up 42%   0% -32%
Arrowhead Pharmaceuticals ARWR NASDAQ Health Care Gene Editing - Cell Therapies USD 85.64 8.9 B 133.2% Strong Up 64%   0% -32%
Ascendis Pharma ASND NASDAQ Health Care Biopharmaceuticals USD 140.95 7.4 B -3.5% Neutral 36%   0% -33%
Asertio Therapeutics ASRT NASDAQ Health Care Biopharmaceuticals USD 1.63 71 M -51.8% Neutral 99%   0% -70%
Atara Biotherapeutics ATRA NASDAQ Health Care Immunotherapy USD 15.01 1.3 B 41.3% Neutral 58%   0% -51%
Athenex ATNX NASDAQ Health Care Drug Manufacturers - Diversified USD 4.70 439 M -64.6% Neutral 103%   0% -75%
Aurinia Pharmaceuticals AUPH NASDAQ Health Care Clinical trial work USD 13.00 1.7 B -22.2% Neutral 64%   0% -47%
Avadel Pharmaceuticals (ADR) AVDL NASDAQ Health Care Biopharmaceuticals USD 7.85 459 M -17.0% Neutral 65%   0% -47%
AVROBIO AVRO NASDAQ Health Care Gene Editing - Cell Therapies USD 9.34 389 M -57.8% Neutral 77%   1% -65%
Beam Therapeutics BEAM NASDAQ Health Care Gene Editing - Cell Therapies USD 85.00 5.3 B 211.4% Weak Up 88%   1% -47%
BeiGene BGNE NASDAQ Health Care Gene Editing - Cell Therapies USD 321.81 30 B 76.2% Neutral 51%   0% -30%
Bellicum Pharmaceuticals BLCM NASDAQ Health Care Biopharmaceuticals USD 3.27 27 M -63.4% Weak Up 97%   1% -71%
Bio-Techne TECH NASDAQ Health Care Diagnostics USD 431.90 17 B 67.8% Weak Up 35%   0% -16%
BioCryst Pharmaceuticals BCRX NASDAQ Health Care Biopharmaceuticals USD 15.89 2.8 B 308.5% Strong Up 83%   1% -30%
Biogen BIIB NASDAQ Health Care Biopharmaceuticals USD 388.44 59 B 43.3% Strong Up 66%   0% -34%
BioMarin Pharmaceutical BMRN NASDAQ Health Care Biopharmaceuticals USD 81.90 15 B -34.0% Neutral 52%   0% -45%
Black Diamond Therapeutics BDTX NASDAQ Health Care Oncology USD 12.55 454 M -69.7% Sharp Down 77%   0% -72%
bluebird bio, Inc. BLUE NASDAQ Health Care Biopharmaceuticals USD 33.15 2.2 B -48.4% Weak Up 68%   0% -62%
Blueprint Medicines Corp BPMC NASDAQ Health Care Biopharmaceuticals USD 82.79 4.8 B 5.1% Weak Down 44%   0% -33%
Cabaletta Bio CABA NASDAQ Health Care Gene Editing - Cell Therapies USD 7.47 180 M -12.8% Sharp Down 73%   0% -53%
Calyxt CLXT NASDAQ Agriculture Farm Crops & Crop Protection USD 4.42 164 M -18.1% Neutral 98%   1% -68%
Cara Therapeutics CARA NASDAQ Health Care Cannabinoid Therapeutics USD 14.55 726 M -12.5% Neutral 75%   0% -58%
Cellectis (ADR) CLLS NASDAQ Health Care Gene Editing - Cell Therapies USD 14.85 635 M -14.9% Sharp Down 81%   1% -57%
Cerus Corporation CERS NASDAQ Health Care Medical Devices USD 5.71 961 M -9.7% Neutral 49%   0% -38%
ChemoCentryx, Inc. CCXI NASDAQ Health Care Biopharmaceuticals USD 13.51 940 M -76.9% Sharp Down 125%   1% -86%
Chimerix CMRX NASDAQ Health Care Biopharmaceuticals USD 8.35 715 M 168.5% Neutral 87%   0% -31%
China Biologic Products CBPO NASDAQ Health Care Biopharmaceuticals USD 119.99 4.7 B 9.9% Neutral 10%   0% -7%
Clovis Oncology, Inc. CLVS NASDAQ Health Care Biopharmaceuticals USD 5.97 624 M -10.5% Weak Up 90%   1% -51%
Cogent Biosciences COGT NASDAQ Health Care Immunotherapy USD 9.27 345 M 363.5% Neutral 180%   0% -44%
Coherus BioSciences CHRS NASDAQ Health Care Biopharmaceuticals USD 14.15 1.0 B -18.3% Neutral 45%   0% -39%
Collegium Pharmaceutical COLL NASDAQ Health Care Biopharmaceuticals USD 22.37 777 M 26.2% Neutral 44%   0% -20%
Corbus Pharmaceuticals Holdings CRBP NASDAQ Health Care Cannabinoid Therapeutics USD 1.99 249 M -74.1% Strong Up 174%   1% -90%
Corvus Pharmaceuticals CRVS NASDAQ Health Care Biopharmaceuticals USD 2.73 105 M -8.4% Neutral 93%   0% -54%
Crinetics Pharmaceuticals CRNX NASDAQ Health Care Clinical trial work USD 21.15 699 M -9.0% Weak Up 67%   1% -48%
CRISPR Therapeutics CRSP NASDAQ Health Care Gene Editing - Cell Therapies USD 127.83 10 B 85.0% Weak Up 63%   1% -52%
Curis Inc. CRIS NASDAQ Health Care Biopharmaceuticals USD 7.54 690 M 508.1% Sharp Down 184%   1% -54%
Cymabay Therapeutics CBAY NASDAQ Health Care Clinical trial work USD 4.63 319 M 17.5% Weak Up 74%   1% -56%
Cytokinetics Inc. CYTK NASDAQ Health Care Biopharmaceuticals USD 21.31 1.5 B -9.2% Weak Down 83%   0% -47%
CytomX Therapeutics CTMX NASDAQ Health Care Biopharmaceuticals USD 7.18 465 M -13.0% Sharp Down 59%   1% -32%
DBV Technologies (ADR) DBVT NASDAQ Health Care Clinical trial work USD 6.06 666 M 12.8% Neutral 102%   0% -76%
Deciphera Pharmaceuticals DCPH NASDAQ Health Care Clinical trial work USD 37.36 2.2 B -40.4% Neutral 52%   0% -51%
Denali Therapeutics DNLI NASDAQ Health Care Clinical trial work USD 73.73 8.9 B 212.3% Strong Up 74%   1% -46%
Dicerna Pharmaceuticals DRNA NASDAQ Health Care Biopharmaceuticals USD 36.18 2.8 B 50.5% Strong Up 55%   0% -36%
Eagle Pharmaceuticals Inc EGRX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 42.89 567 M -4.8% Neutral 37%   0% -28%
Editas Medicine EDIT NASDAQ Health Care Gene Editing - Cell Therapies USD 35.88 2.4 B 11.6% Neutral 84%   1% -65%
Eidos Therapeutics EIDX NASDAQ Health Care Clinical trial work USD 122.21 4.7 B 151.6% Neutral 52%   0% -11%
Eiger BioPharmaceuticals EIGR NASDAQ Health Care Biopharmaceuticals USD 8.23 279 M -24.8% Neutral 64%   0% -38%
Eloxx Pharmaceuticals ELOX NASDAQ Health Care Clinical trial work USD 2.08 84 M -39.9% Weak Up 81%   0% -70%
Enanta Pharmaceuticals Inc ENTA NASDAQ Health Care Biopharmaceuticals USD 45.74 923 M -7.0% Weak Down 36%   0% -23%
Endo International ENDP NASDAQ Health Care Drug Manufacturers - Generic USD 5.22 1.2 B 48.7% Neutral 66%   0% -51%
Epizyme, Inc. EPZM NASDAQ Health Care Biopharmaceuticals USD 8.59 874 M -54.4% Neutral 65%   0% -64%
Esperion Therapeutics ESPR NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 24.72 691 M -43.2% Weak Up 67%   0% -63%
Evolus EOLS NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 12.77 558 M 134.7% Strong Up 110%   0% -49%
Exelixis EXEL NASDAQ Health Care Oncology USD 22.41 7.0 B -7.3% Weak Down 40%   0% -32%
EyePoint Pharmaceuticals EYPT NASDAQ Health Care Biopharmaceuticals USD 9.55 274 M 7.8% Neutral 85%   0% -42%
Fate Therapeutics FATE NASDAQ Health Care Oncology USD 80.23 7.5 B 152.9% Weak Up 75%   1% -43%
FibroGen FGEN NASDAQ Health Care Biopharmaceuticals USD 26.96 2.5 B -32.2% Weak Up 80%   0% -67%
Five Prime Therapeutics FPRX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 38.00 1.4 B 764.6% Strong Up 155%   0% -38%
Flexion Therapeutics FLXN NASDAQ Health Care Biopharmaceuticals USD 9.16 457 M -27.9% Weak Up 59%   0% -50%
Forma Therapeutics Holdings FMTX NASDAQ Health Care Clinical trial work USD 25.99 1.2 B -33.4% Weak Down 72%   0% -55%
Frequency Therapeutics FREQ NASDAQ Health Care Biopharmaceuticals USD 9.97 341 M -56.5% Neutral 170%   1% -85%
G1 Therapeutics GTHX NASDAQ Health Care Biopharmaceuticals USD 20.95 879 M -11.8% Neutral 69%   1% -55%
Galapagos GLPG NASDAQ Health Care Biopharmaceuticals USD 73.77 4.8 B -64.4% Neutral 54%   0% -66%
Gamida Cell GMDA NASDAQ Health Care Oncology USD 6.28 371 M 25.1% Neutral 79%   0% -53%
Generation Bio GBIO NASDAQ Health Care Gene Editing - Cell Therapies USD 24.34 1.4 B 11.1% Weak Down 85%   1% -53%
Genmab A/S GMAB NASDAQ Health Care Biopharmaceuticals USD 42.92 28 B 35.4% Strong Up 33%   0% -30%
Geron GERN NASDAQ Health Care Drug Manufacturers - Diversified USD 1.83 583 M -5.2% Neutral 61%   1% -43%
Gilead Sciences GILD NASDAQ Health Care Biopharmaceuticals USD 66.61 84 B -11.3% Neutral 22%   0% -26%
Global Blood Therapeutics GBT NASDAQ Health Care Biopharmaceuticals USD 36.64 2.3 B -45.7% Neutral 67%   0% -52%
GlycoMimetics GLYC NASDAQ Health Care Clinical trial work USD 2.33 120 M -21.8% Neutral 61%   0% -57%
Grifols SA GRFS NASDAQ Health Care Drug Manufacturers - Diversified USD 17.83 12 B -7.4% Neutral 33%   0% -24%
GW Pharmaceuticals (ADR) GWPH NASDAQ Health Care Cannabinoid Therapeutics USD 218.96 6.8 B 68.8% Strong Up 54%   0% -36%
Halozyme Therapeutics HALO NASDAQ Health Care Biopharmaceuticals USD 41.41 5.6 B 69.4% Neutral 43%   0% -25%
Homology Medicines FIXX NASDAQ Health Care Gene Editing - Cell Therapies USD 6.86 346 M -55.5% Weak Up 68%   1% -64%
Horizon Pharma HZNP NASDAQ Health Care Biopharmaceuticals USD 94.61 21 B 89.3% Neutral 49%   0% -21%
Hutchison China MediTech HCM NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 29.20 3.9 B 23.7% Neutral 43%   0% -36%
I-Mab IMAB NASDAQ Health Care Immunotherapy USD 73.41 976 M 137.0% Strong Up 75%   0% -31%
IDEAYA Biosciences IDYA NASDAQ Health Care Oncology USD 22.69 732 M 54.4% Weak Up 66%   0% -28%
Illumina ILMN NASDAQ Health Care Gene Editing - Cell Therapies USD 456.16 67 B 23.7% Weak Up 40%   0% -27%
Immunogen IMGN NASDAQ Health Care Biopharmaceuticals USD 6.69 1.3 B 54.9% Neutral 68%   1% -45%
Incyte Corporation INCY NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 83.96 18 B -20.3% Neutral 36%   0% -31%
Innoviva INVA NASDAQ Health Care Biopharmaceuticals USD 13.33 1.4 B -4.9% Neutral 39%   0% -39%
Inovio Pharmaceuticals INO NASDAQ Health Care Biopharmaceuticals USD 8.49 1.8 B -40.5% Strong Up 129%   1% -80%
Inozyme Pharma INZY NASDAQ Health Care Biopharmaceuticals USD 15.43 362 M -12.0% Neutral 70%   0% -50%
Insmed INSM NASDAQ Health Care Biopharmaceuticals USD 29.10 3.0 B 0.6% Weak Up 58%   0% -45%
Intellia Therapeutics NTLA NASDAQ Health Care Gene Editing - Cell Therapies USD 75.92 5.1 B 258.6% Weak Up 84%   1% -44%
Intercept Pharmaceuticals ICPT NASDAQ Health Care Biopharmaceuticals USD 19.81 654 M -74.6% Weak Up 87%   1% -81%
Intra-Cellular Therapies, Inc. ITCI NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 43.18 3.5 B 70.6% Strong Up 74%   0% -26%
Ionis Pharmaceuticals IONS NASDAQ Health Care Biopharmaceuticals USD 37.79 5.3 B -35.9% Neutral 44%   0% -46%
Iovance Biotherapeutics IOVA NASDAQ Health Care Immunotherapy USD 24.78 3.6 B -17.3% Weak Up 77%   1% -69%
Ironwood Pharmaceuticals IRWD NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 11.72 1.9 B 22.0% Neutral 38%   0% -26%
iTeos Therapeutics ITOS NASDAQ Health Care Oncology USD 25.07 880 M 31.6% Weak Up 77%   0% -60%
Jazz Pharmaceuticals JAZZ NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 177.28 10 B 55.5% Neutral 32%   0% -12%
Jounce Therapeutics JNCE NASDAQ Health Care Immunotherapy USD 7.27 330 M 15.0% Sharp Down 94%   1% -50%
Kadmon Holdings KDMN NASDAQ Health Care Drug Manufacturers - Generic USD 3.99 - -13.4% Weak Up 63%   1% -39%
Kala Pharmaceuticals KALA NASDAQ Health Care Biopharmaceuticals USD 5.86 361 M -57.1% Neutral 68%   0% -63%
Karyopharm Therapeutics Inc. KPTI NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 10.58 790 M -44.3% Weak Up 55%   0% -59%
Keros Therapeutics KROS NASDAQ Health Care Clinical trial work USD 53.78 1.3 B 39.6% Neutral 75%   0% -44%
Kiniksa Pharmaceuticals KNSA NASDAQ Health Care Clinical trial work USD 15.02 1.0 B -38.6% Neutral 61%   0% -49%
Kura Oncology KURA NASDAQ Health Care Biopharmaceuticals USD 21.98 1.5 B 17.7% Sharp Down 57%   0% -50%
Lexicon Pharmaceuticals LXRX NASDAQ Health Care Diabetes USD 4.64 670 M 137.9% Weak Up 117%   1% -55%
Ligand Pharmaceuticals LGND NASDAQ Health Care Clinical trial work USD 126.61 2.1 B 8.9% Neutral 55%   0% -48%
Luminex Corp LMNX NASDAQ Health Care Diagnostics USD 36.79 1.7 B 29.8% Weak Up 48%   0% -49%
Lumos Pharma LUMO NASDAQ Health Care Biopharmaceuticals USD 10.79 90 M -33.4% Neutral 65%   0% -73%
MacroGenics MGNX NASDAQ Health Care Biopharmaceuticals USD 21.89 1.2 B -24.0% Sharp Down 61%   0% -42%
Magenta Therapeutics MGTA NASDAQ Health Care Gene Editing - Cell Therapies USD 10.80 524 M 11.5% Neutral 67%   0% -41%
MannKind Corporation MNKD NASDAQ Health Care Diabetes USD 4.26 1.1 B 120.7% Neutral 90%   1% -48%
Marinus Pharmaceuticals MRNS NASDAQ Health Care Clinical trial work USD 18.50 677 M 69.4% Strong Up 79%   0% -26%
MediciNova Inc. MNOV NASDAQ Health Care Drug Manufacturers - Diversified USD 3.76 183 M -30.6% Neutral 105%   0% -66%
Medpace Holdings MEDP NASDAQ Health Care Medical Laboratories & Research USD 177.54 6.3 B 97.4% Weak Up 38%   0% -18%
Mersana Therapeutics MRSN NASDAQ Health Care Biopharmaceuticals USD 13.76 950 M -31.2% Neutral 73%   1% -50%
Minerva Neurosciences NERV NASDAQ Health Care Biopharmaceuticals USD 2.63 112 M -25.5% Neutral 70%   0% -44%
Mirati Therapeutics MRTX NASDAQ Health Care Oncology USD 166.56 8.4 B 45.3% Weak Up 45%   0% -40%
Myriad Genetics MYGN NASDAQ Health Care Diagnostics USD 28.61 2.2 B 138.6% Neutral 57%   0% -20%
Nabriva Therapeutics NBRV NASDAQ Health Care Clinical trial work USD 1.34 335 M -83.8% Sharp Down 80%   0% -85%
NanoString Technologies NSTG NASDAQ Health Care Diagnostics USD 64.19 2.9 B 95.9% Weak Up 64%   1% -42%
NantHealth NH NASDAQ Health Care Health Care Information Technology USD 2.54 283 M -27.4% Neutral 89%   0% -67%
Nektar Therapeutics NKTR NASDAQ Health Care Clinical trial work USD 17.00 3.1 B -25.5% Weak Down 46%   0% -36%
Neoleukin Therapeutics NLTX NASDAQ Health Care Immunotherapy USD 10.15 430 M -40.1% Neutral 72%   1% -45%
Neos Therapeutics NEOS NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 1.15 57 M 47.4% Strong Up 92%   0% -39%
Neurocrine Biosciences NBIX NASDAQ Health Care Biopharmaceuticals USD 100.52 9.4 B -22.0% Weak Up 44%   0% -36%
Neuronetics STIM NASDAQ Health Care Biopharmaceuticals USD 16.85 428 M 825.8% Strong Up 102%   0% -52%
Nkarta NKTX NASDAQ Health Care Gene Editing - Cell Therapies USD 26.48 868 M -0.4% Neutral 80%   0% -68%
Novavax NVAX NASDAQ Health Care Clinical trial work USD 174.41 13 B 169.4% Weak Up 116%   1% -62%
NovoCure NVCR NASDAQ Health Care Oncology USD 218.04 22 B 244.1% Weak Up 67%   0% -35%
Nurix Therapeutics NRIX NASDAQ Health Care Biopharmaceuticals USD 28.94 1.1 B 51.4% Weak Up 101%   1% -62%
Ocular Therapeutix OCUL NASDAQ Health Care Biopharmaceuticals USD 13.51 1.0 B 52.2% Sharp Down 68%   0% -41%
Omeros Corp OMER NASDAQ Health Care Biopharmaceuticals USD 15.06 933 M -2.2% Sharp Down 74%   0% -55%
OPKO Health OPK NASDAQ Health Care Diagnostics USD 3.70 2.5 B 55.5% Neutral 79%   0% -50%
OptiNose OPTN NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 3.62 192 M -42.3% Weak Up 74%   0% -61%
ORIC Pharmaceuticals ORIC NASDAQ Health Care Oncology USD 19.98 733 M -41.4% Sharp Down 78%   0% -53%
Pacific Biosciences of California PACB NASDAQ Health Care Medical Technology USD 29.15 5.6 B 730.5% Weak Up 86%   1% -56%
Pacira Pharmaceuticals PCRX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 59.64 2.6 B 32.4% Weak Down 40%   0% -25%
Paratek Pharmaceuticals PRTK NASDAQ Health Care Biopharmaceuticals USD 7.39 347 M 52.4% Neutral 63%   0% -32%
Passage Bio PASG NASDAQ Health Care Gene Editing - Cell Therapies USD 14.36 773 M -57.4% Neutral 80%   1% -66%
PDL BioPharma PDLI NASDAQ Health Care Biopharmaceuticals USD 2.47 288 M 4.0% Weak Down 38%   0% -22%
PetIQ PETQ NASDAQ Health Care Veterinary Services USD 40.02 1.2 B 26.3% Neutral 44%   0% -33%
Pliant Therapeutics PLRX NASDAQ Health Care Biopharmaceuticals USD 28.93 1.0 B 3.3% Neutral 81%   0% -44%
PRA Health Sciences PRAH NASDAQ Health Care Clinical trial work USD 167.19 11 B 72.6% Neutral 31%   0% -11%
Precigen PGEN NASDAQ Health Care Biopharmaceuticals USD 6.35 1.3 B 27.3% Neutral 92%   1% -43%
ProQR Therapeutics PRQR NASDAQ Health Care Gene Editing - Cell Therapies USD 7.59 411 M 17.7% Weak Up 82%   0% -38%
Prothena Corp PRTA NASDAQ Health Care Biopharmaceuticals USD 51.01 2.0 B 414.7% Strong Up 88%   0% -15%
Provention Bio PRVB NASDAQ Health Care Immunotherapy USD 8.37 530 M -50.8% Neutral 81%   1% -66%
PTC Therapeutics PTCT NASDAQ Health Care Biopharmaceuticals USD 44.64 3.1 B -12.5% Weak Up 43%   0% -45%
Puma Biotechnology PBYI NASDAQ Health Care Biopharmaceuticals USD 9.88 398 M -12.6% Neutral 55%   0% -32%
Quanterix QTRX NASDAQ Health Care Medical Laboratories & Research USD 64.44 2.3 B 139.3% Weak Up 77%   1% -52%
Radius Health RDUS NASDAQ Health Care Biopharmaceuticals USD 18.53 869 M 30.3% Weak Down 55%   0% -30%
Regeneron Pharmaceuticals REGN NASDAQ Health Care Biopharmaceuticals USD 537.92 58 B -16.5% Neutral 31%   0% -32%
REGENXBIO RGNX NASDAQ Health Care Gene Editing - Cell Therapies USD 37.74 1.6 B 2.2% Weak Up 51%   0% -35%
Relay Therapeutics RLAY NASDAQ Health Care Oncology USD 35.34 3.2 B 0.8% Weak Up 70%   0% -55%
Relmada Therapeutics RLMD NASDAQ Health Care Clinical trial work USD 30.90 517 M -35.3% Weak Down 51%   0% -41%
Repare Therapeutics RPTX NASDAQ Health Care Oncology USD 34.02 1.3 B 10.5% Neutral 62%   0% -42%
Repligen RGEN NASDAQ Health Care Products & Processes USD 197.34 11 B 70.7% Neutral 43%   0% -27%
Replimune Group REPL NASDAQ Health Care Immunotherapy USD 35.40 1.6 B 63.3% Neutral 77%   0% -46%
Revance Therapeutics, Inc. RVNC NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 30.40 2.2 B 30.8% Neutral 48%   0% -32%
Revolution Medicines RVMD NASDAQ Health Care Oncology USD 33.96 2.5 B -9.8% Neutral 69%   0% -47%
Rhythm Pharmaceuticals RYTM NASDAQ Health Care Biopharmaceuticals USD 20.51 1.0 B -8.1% Neutral 63%   0% -53%
Rigel Pharmaceuticals RIGL NASDAQ Health Care Biopharmaceuticals USD 4.22 718 M 134.4% Weak Up 94%   1% -46%
Rocket Pharmaceuticals RCKT NASDAQ Health Care Gene Editing - Cell Therapies USD 43.01 2.7 B 107.8% Neutral 85%   0% -40%
Rubius Therapeutics RUBY NASDAQ Health Care Gene Editing - Cell Therapies USD 25.20 2.0 B 289.5% Neutral 125%   1% -30%
SAGE Therapeutics SAGE NASDAQ Health Care Clinical trial work USD 56.88 3.3 B 40.7% Weak Down 56%   0% -43%
Sangamo Therapeutics SGMO NASDAQ Health Care Gene Editing - Cell Therapies USD 11.34 1.6 B 28.6% Neutral 77%   1% -44%
Sanofi (ADR) SNY NASDAQ Health Care Drug Manufacturers - Diversified USD 52.86 133 B 1.0% Neutral 21%   0% -16%
Savara SVRA NASDAQ Health Care Clinical trial work USD 1.77 96 M -32.2% Weak Up 82%   0% -67%
Seagen SGEN NASDAQ Health Care Oncology USD 156.31 28 B -8.0% Weak Up 42%   0% -36%
Seres Therapeutics MCRB NASDAQ Health Care Biopharmaceuticals USD 21.83 2.0 B 354.8% Neutral 177%   1% -53%
SIGA Technologies SIGA NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 6.37 489 M 7.8% Weak Down 38%   0% -19%
Sio Gene Therapies SIOX NASDAQ Health Care Clinical trial work USD 2.70 131 M -12.9% Weak Up 100%   1% -66%
Solid Biosciences SLDB NASDAQ Health Care Clinical trial work USD 3.91 333 M 22.6% Neutral 125%   0% -67%
Spectrum Pharmaceuticals SPPI NASDAQ Health Care Biopharmaceuticals USD 4.27 656 M 31.4% Strong Up 68%